title: The Urinary Excretion of Pyridinium Cross-links as Markers of Bone Meta stasisin Breast Cancer.
abstract: The collagen cross-links, pyridinoline (Pyr) and deoxypyridinoline (D-Pyr) excreted in urine have recently been suggested as new markers of bone metastasis. In a pilot study we measured Pyr and D-Pyr in 61 patients with breast cancer, 16 with known bone metastasis and 45 with no recognized metastasis in bone. Twenty healthy female subjects were also measured as controls. The mean values (+/-SD) of Pyr and D-Pyr in the group with bone metastasis were significantly higher (Pyr: p<0.01, D-Pyr: p <0.05) than those in the group without bone metastasis and in the control group. The mean (+/-SD) values of postmenopausal women were significantly higher than those of premenopausal in the group without bone metastasis (p<0.05) and in the control group (p<0.01). Therefore, the effect of menopause should be taken into account in the diagnosis of bone metastasis by assays of Pyr and D-Pyr. Setting the cut-off values (mean + 2SD of the values of control) for pre and postmenopausal patients, the accuracy for Pyr was 71.4% in premenopausal and 75.8% in postmenopausal patients; and for D-Pyr it was 71.4% and 78.8% respectively. We consider that measurement of urinary collagen cross-links assays can contribute to the early detection of metastatic spread to bone in breast cancer.
authors.affiliation: First Department of Surgery, National Defense Medical College, 3-2 Namiki, Tokorozawa 359, Japan.
authors.initials: H
authors.lastname: Hiraide
authors.initials: S
authors.lastname: Okamura
authors.initials: T
authors.lastname: Hayashi
authors.initials: M
authors.lastname: Nishida
authors.initials: K
authors.lastname: Tamaki
authors.initials: S
authors.lastname: Tamakuma